Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of

Sebastiaan De Schepper1, Judy Z Ge1, Gerard Crowley2,3

  • 1UK Dementia Research Institute, Institute of Neurology, University College London, London, UK.

Nature Neuroscience
|February 6, 2023
PubMed

Insights

Secreted phosphoprotein 1 (SPP1) drives microglia to engulf synapses in Alzheimer's disease (AD) models. Blocking SPP1 prevents synaptic loss, highlighting a new therapeutic target for AD.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Alzheimer's disease (AD) involves synaptic loss, potentially driven by microglial dysfunction.
  • The specific signals prompting microglia to engulf synapses in AD remain largely unknown.

Purpose of the Study:

  • To investigate the role of secreted phosphoprotein 1 (SPP1) in microglia-mediated synaptic engulfment in Alzheimer's disease models.
  • To elucidate the signaling pathways involved in perivascular cell-to-microglia communication in AD.

Main Methods:

  • Upregulation analysis of SPP1 in perivascular macrophages and fibroblasts.
  • Functional assays in AD mouse models to assess the impact of SPP1 on synaptic engulfment and loss.
  • Single-cell RNA sequencing and cell-cell interaction analyses to identify molecular mechanisms.

Main Results:

  • Secreted phosphoprotein 1 (SPP1) is upregulated by perivascular cells in AD mouse models.
  • Perivascular SPP1 is essential for microglia to engulf synapses and upregulate phagocytic markers in the presence of amyloid-beta oligomers.
  • Absence of SPP1 expression prevents synaptic loss in AD mouse models.
  • SPP1 signaling induces microglial phagocytic states in the hippocampus.

Conclusions:

  • SPP1 plays a critical role in perivascular cell-to-microglia crosstalk, modulating synaptic engulfment in AD.
  • Targeting SPP1 may offer a novel therapeutic strategy to prevent synaptic loss in Alzheimer's disease.

Related Concept Videos